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The particulate methane monooxygenase (pMMO) is
known to be very difficult to study mainly due to its
unusual activity instability in vitro. By cultivating
Methylococcus capsulatus (Bath) under methane stress
conditions and high copper levels in the growth me-
dium, membranes highly enriched in the pMMO with
exceptionally stable activity can be isolated from these
cells. Purified and active pMMO can be subsequently
obtained from these membrane preparations using pro-
tocols in which an excess of reductants and anaerobic
conditions were maintained during membrane solubili-
zation by dodecyl b-D-maltoside and purification by
chromatography. The pMMO was found to be the major
constituent in these membranes, constituting 60–80% of
total membrane proteins. The dominant species of the
pMMO was found to consist of three subunits, a, b, and g,
with an apparent molecular mass of 45, 26, and 23 kDa,
respectively. A second species of the pMMO, a proteo-
lytically processed version of the enzyme, was found to
be composed of three subunits, a*, b, and g, with an
apparent molecular mass of 35, 26, and 23 kDa, respec-
tively. The a and a* subunits from these two forms of the
pMMO contain identical N-terminal sequences. The g
subunit, however, exhibits variation in its N-terminal
sequence. The pMMO is a copper-containing protein
only and shows a requirement for Cu(I) ions. Approxi-
mately 12–15 Cu ions per 94-kDa monomeric unit were
observed. The pMMO is sensitive to dioxygen tension.
On the basis of dioxygen sensitivity, three kinetically
distinct forms of the enzyme can be distinguished. A
slow but air-stable form, which is converted into a
“pulsed” state upon direct exposure to atmospheric ox-
ygen pressure, is considered as type I pMMO. This form
was the subject of our pMMO isolation effort. Other
forms (types II and III) are deactivated to various ex-
tents upon exposure to atmospheric dioxygen pressure.
Under inactivating conditions, these unstable forms re-
lease protons to the buffer (;10 H1/94-kDa monomeric
unit) and eventually become completely inactive.
The enzyme methane monooxygenase, found in methanotro-
phic bacteria, catalyzes the conversion of methane to methanol
using dioxygen as a co-substrate at ambient temperatures and
pressures (1, 2). This system has attracted considerable atten-
tion, since it provides an ideal natural model to study methane
activation and functionalization, a subject of significant cur-
rent interest (3). Two distinct species of methane monooxyge-
nase (MMO)1 are known to exist at different cellular locations,
a cytoplasmic (soluble) MMO and a membrane-bound (partic-
ulate) MMO (4). The soluble MMO (sMMO) is a complex three-
component system consisting of a hydroxylase, a reductase,
and a small regulatory protein (4). The sMMO has been inves-
tigated extensively by several research groups (5–21). The x-
ray crystal structure of the sMMO hydroxylase isolated from
Methylococcus capsulatus (Bath) has been solved (22, 23). The
hydroxylase active site contains a non-heme binuclear iron
cluster. In contrast, the particulate methane monooxygenase
(pMMO) appears to be a copper protein (24–29). This enzyme is
much less well characterized mainly due to its unusual activity
instability.
Despite the lability of the enzyme activity in vitro, the
pMMO appears to be expressed in all methanotrophs (1, 2, 4).
So far, the sMMO has been detected in only the following
strains and species: M. capsulatus, Methylosinus trichospo-
rium, Methylosinus sporium, Methylocystis sp. M and Methyl-
omonas methanica 68–1 (6, 30–34). In strains capable of ex-
pressing either the sMMO or pMMO, the sMMO is expressed
under copper stress only (low copper/biomass ratio) (35–39).
Otherwise, the pMMO is expressed. Copper ions not only reg-
ulate the expression of the pMMO but have been found to be
crucial for pMMO activity. The expression of the pMMO is
accompanied by the formation of an extensive network of in-
tracytoplasmic membranes, where the membrane-bound
pMMO resides (35–39). An increase in carbon to biomass con-
version efficiency is also observed. Three new polypeptides with
apparent molecular masses of 45, 35, and 26 kDa were ob-
served in the membrane fractions when M. capsulatus (Bath)
switched from expressing the sMMO to the pMMO (35–39).
Recent progress in our laboratory indicates that the pMMO
is a novel copper-containing enzyme. Metal/protein ratio data
analysis clearly suggests that the pMMO is a multiple copper-
containing enzyme (24–26, 28, 29, 40). Activity was found to be
proportional to the level of membrane-bound copper ions (24,
27–29). The pMMO-associated copper ions appear to be orga-
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nized into trinuclear cluster units with rather defined magnetic
and redox properties (24–26, 28, 29, 40). The as-isolated
pMMO-enriched membranes often contain a mixture of Cu(I)
and Cu(II) ions in various proportions, depending on the han-
dling of the samples (25, 26, 28, 29, 40). Hence, the functional
form of the enzyme has been suggested to be the reduced or
partially reduced form. The chemistry catalyzed by this en-
zyme is also highly specific. pMMO-catalyzed hydroxylation of
cryptically chiral ethanes has implicated a reaction mechanism
proceeding with complete retention of alkane substrate config-
uration (41, 42). This extraordinary chemistry currently has no
precedent in known model and biological systems. Accordingly,
insights regarding the copper-containing active site of the
pMMO can provide a new direction in the design of biominetic
catalysts for methane activation and functionalization.
The pMMO has been known to be very difficult to study. As
noted earlier, one of the main obstacles in studying the pMMO
is the unusual instability of the activity of the enzyme. Activity
is frequently lost upon cell lysis, detergent solubilization, and
freeze-thaw cycles. In several cultures, no activity was ob-
served in cell-free extracts, or activity quickly disappeared
within 6 h after cell lysis (24–26, 28, 29, 40). Enzymatic activity
is also known to be very sensitive to exogenous ligands as well
as the choice of buffer. This highly unusual instability has
hampered efforts in characterizing the pMMO. The addition of
copper ions is known to enhance enzymatic activity under
certain conditions (cells grown at low copper levels), but the
effect of copper ions in the extension of pMMO activity is not
known. No reagent is currently known to reactivate the enzyme
once the protein becomes inactive. As a result, a highly active,
stable, and purified preparation of the enzyme has been slow in
forthcoming.
Past efforts in isolating the pMMO have resulted in signifi-
cant confusion regarding the nature of the enzyme. An early
report of pMMO isolation from M. trichosporium OB3b indi-
cates that this system can utilize ascorbate in addition to
NADH as electron donors and was found to consist of three
components: a 47-kDa polypeptide containing various amounts
of copper, a smaller 9.4-kDa subunit, and a 13-kDa CO-binding
cytochrome c (43). In later studies, the aforementioned ascor-
bate-linked activity was not observed, and attempts to solubi-
lize the enzyme resulted in complete deactivation of the pro-
tein. Solubilization of pMMO from M. capsulatus (Bath) using
a nonionic detergent was attempted, and upon detergent re-
moval and lipid vesicle reconstitution, partial activity was ob-
served (44). According to the authors, any attempts to purify
the enzyme further resulted in complete loss of activity. A few
reports including a recent work (45, 46) appear to support the
notion that the active site of the pMMO may contain iron
despite the overwhelming evidence accumulated to date sug-
gesting that copper is the element responsible for catalysis
within the enzyme active site. Thus, to advance the field, the
presence of iron and copper in the pMMO must be resolved.
This paper summarizes our efforts to isolate and purify the
pMMO from M. capsulatus (Bath) for biochemical and biophys-
ical characterization. Toward the development of suitable pro-
tocols for pMMO isolation, we have embarked on an extensive
investigation of factors contributing to enzymatic activity sta-
bility, including various methods of bacterial cultivation and
membrane isolation, and various schemes of enzyme stabiliza-
tion and purification. We find that the details of the bacterial
cultivation and isolation methods significantly affect the qual-
ity of the membranes and the protein isolated from them.
Methods of bacterial cultivation and pMMO isolation were
optimized such that active and purified preparations of the
enzyme could be recovered. Active membrane fractions, highly
enriched in pMMO and exhibiting exceptionally stable activity,
were subsequently isolated using various procedures, assayed
for activity, solubilized with detergents, and fractionated using
available methods of protein purification. For such prepara-
tions, activity can be maintained in the membrane-bound
forms for an extended period of time, a minimum of 3–4 days
and up to 10 days at 4 °C with stable or enhanced activity
(stable with respect to repeated freeze-thaw cycles and pro-
longed storage at 280 °C). Aside from describing these proce-
dures in this report, we will discuss several other critical issues
relating to the nature of the pMMO, particularly whether or
not the pMMO is a copper-containing enzyme only, the subunit
composition of the enzyme, and whether or not there is more
than one form of the protein as suggested by recent genetic
data.
MATERIALS AND METHODS
Growth of Methanotrophs and Membrane Isolation—M. capsulatus
(Bath) used in the studies were maintained on Petri plates containing
the nitrate mineral salts medium with added CuSO4 (20 mM) and
solidified with 1.7% agar. Cultures were maintained under an atmo-
sphere of 20% methane in air and streaked onto fresh plates every 4–6
weeks (47). Chemostat cultures (9–10 liters) were grown according to
the following procedure. The organisms were first transferred from
Petri plates to 250-ml flasks and subsequently to 2-liter Erlenmeyer
flasks, containing 40 and 300 ml, respectively, of the nitrate mineral
salts medium with added CuSO4 (10 mM), a 20% methane in air atmo-
sphere, and continual shaking. The organisms were allowed to grow for
48 h in these small scale cultures. The 300-ml cultures were used to
seed a fermentor containing 9 liters of the above described medium with
added 20 mM CuSO4 and 20 mM CuEDTA. The methane feeding rate was
controlled such that methane is growth-limiting (feeding rate ;0.01–
0.012 feet3/hzliter). The methane/air ratio was 1:4. A cell density of .10
g/liter of culture can be obtained at a higher methane feeding rate.
However, the employed methane feeding rate, termed as methane
stress condition (semistarvation growth condition), results in less bio-
mass; typically only ;5–6 g of wet cells/liter would be obtained. How-
ever, this condition was found to stimulate the overproduction of the
intracytoplasmic membranes, which also contain exceptionally high
levels of the pMMO (see below). Furthermore, it also stimulates copper
uptake (high copper/protein ratio), resulting in exceptionally high
pMMO specific activity. Approximately 24 h after inoculation and 6 h
prior to cell harvest, additional CuSO4 (or CuEDTA) was added to bring
the total added copper concentration to 50 and 60 mM, respectively. Six
h and 3 h prior to cell harvest, the methane feeding rate was increased
incrementally to 0.03–0.04 feet3/hzliter to relieve the starvation condi-
tion (partly to increase cell density). Without this step, the activity was
not stable although the membranes contained unusually high levels of
the pMMO. M. capsulatus (Bath) was grown at 42 °C. The pH must be
maintained at 6.8–7.4 during growth. Cells were harvested in late log
phase (typically 48–52 h after inoculation) by centrifugation at
27,000 3 g for 15 min and washed twice with 50 mM Pipes (pH 7.2).
Washed cells were suspended in lysis buffer containing 50 mM Pipes, 4
mM ascorbate, 50 mg of catalase/ml of buffer, pH ;7.2 (typically 60 g of
wet cells and buffer to a volume of ;75 ml of cell suspension). Cu(II)
ions (100 mM CuSO4) can also be added to this buffer to improve the
enzyme stability further. However, the addition of copper often caused
the ascorbate-containing buffer to lose its effectiveness rather quickly
and would complicate metal content analysis of the purified protein, so
it was routinely omitted.
Cell suspensions (;0.8–1.0 g of cells/ml) were passed three times
through a French pressure cell at 20,000 p.s.i. to separate the cytosolic
and membrane fractions. Less dense cell suspensions (,0.5 g of cells/
ml) often result in low activity or completely inactive cell-free extract
and membranes. It appeared that the dense cell suspensions used here
(i) kept the dioxygen tension low, hence minimizing copper oxidation
and (ii) resulted in highly viscous lysate, which helped to protect the
integrity of the membrane-bound pMMO during the isolation process.
Unlysed cells and cell debris were removed by centrifugation at
27,000 3 g for 40 min. The supernatant was then ultracentrifuged at
220,000 3 g for 90 min to pellet the membrane fraction. The clear
supernatant obtained after ultracentrifugation was used as the cytoso-
lic fraction. The pelleted membranes often show distinct layers. The
minor bottom layer containing bluish and black materials and the thin,
white top layer were discarded. Only the middle layer, or the translu-
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cent intracytoplasmic membranes, constituting the bulk of the mem-
brane fractions, were collected. These membranes can be separated
further on the basis of their texture into “soft” and “hard” membranes,
albeit with difficulty. The difference between these two types of mem-
branes is not great although the hard membranes appear to have higher
intact pMMO content. The translucent membranes were washed by
suspending them in washing buffer containing 50 mM Pipes, 5 mM
ascorbate, 25 mg of catalase/ml (pH 7.2) using a Dounce homogenizer,
repelleted by ultracentrifugation, and resuspended in washing buffer of
2–3 times the volume of the original cell suspension. This process was
repeated a few more times until the supernatant was virtually free of
soluble proteins. Finally, the pelleted membranes were suspended in
storage buffer (low ionic strength storage buffer, 20–25 mM Pipes, 5 mM
ascorbate, 25 mg of catalase/ml of buffer, pH ;7.25; or high ionic
strength storage buffer, 75–100 mM Pipes, 50 mM imidazole, 5 mM
ascorbate, 25 mg of catalase/ml of buffer, pH ;7.25) in a volume equal
to the original cell suspension volume. Sucrose (200 mM) can also be
added to the above buffers to improve stability further. The membrane
suspensions then can be kept at 4 °C or frozen at liquid nitrogen
temperature and stored at 280 °C for future use. It should be noted that
activity was found to quickly decrease if the membranes were too dilute
(i.e. the storage buffer volume was several times higher than that of the
original cell suspension).
Membrane Solubilization—The membrane suspension was first de-
gassed by several vacuum/argon cycles. The membranes in storage
buffer (in either low or high ionic strength buffer) were then treated
with either solid or 20% (w/v) stock solution of dodecyl b-D-maltoside (to
a final concentration of 3–5% (w/v) or ;2 mg of detergent/mg of protein).
The mixture was mixed rigorously and incubated on ice for 30 min to 1 h
and then centrifuged at 37,000 3 g for 45 min to remove unsolubilized
materials. The clear supernatant was taken as the solubilized mem-
branes, and used for subsequent steps.
Rapid Isolation Procedure Using L-Lysine-Agarose Affinity Chroma-
tography and Removal of Positively Charged and Iron-containing Pro-
teins—The L-lysine-agarose column (Sigma) (20 3 2 cm) was equili-
brated with buffer containing 25 mM Pipes, 5 mM ascorbate, with or
without 200 mM CuSO4 and 0.05% (w/v) dodecyl b-D-maltoside, pH
;7.25. Dithionite (5 mM) can be used in lieu of ascorbate; however,
strict anaerobic protocol must be followed. The solubilized membranes
(;2 ml; ;40–60 mg of total protein) were applied to the column, and
0.5-ml effluent fractions were collected, employing an elution buffer of
20–25 mM Pipes, 5 mM ascorbate, 0.05% (w/v) dodecyl b-D-maltoside,
pH 7.2, but with no sucrose or imidazole added. The elution rate from
the column was typically 0.5–1.0 ml/min. Three to four fractions can be
obtained. The flow-through fraction contains large pieces of the solubi-
lized membranes and most of the positively charged proteins. A fast
moving fraction contains several proteins (heme-containing proteins)
but also pMMO (purity of ;70% or higher). Next, a slow moving fraction
constitutes the bulk of the solubilized membranes and contains mostly
the three-subunit form of the pMMO (purity of ;90% or higher). Fi-
nally, a minor binding fraction can be eluted out of the column using
buffer containing 50 mM Pipes, 100 mM NaCl, pH ;7.25. This binding
fraction consists of mostly heme-containing proteins but also some
residual pMMO.
Large Scale Isolation Procedure Using Anion Exchange Chromatog-
raphy and Removal of Positively Charged and Iron-containing Pro-
teins—Large scale isolation of the enzyme can also be obtained with a
variation of the above procedure using DEAE-Sepharose Fast Flow
(Amersham Pharmacia Biotech). A DEAE-Sepharose Fast Flow column
was equilibrated with buffer containing 100 mM Pipes, 50 mM imidaz-
ole, 5 mM ascorbate, 200 mM CuSO4, 0.05% (w/v) dodecyl b-D-maltoside
buffer at pH ;7.25. Sucrose (200 mM) can also be included in this buffer,
but its effectiveness is not great. 5–7 ml of solubilized membranes
(concentration 20–30 mg/ml) in high ionic strength storage buffer were
then applied to the column. When an anaerobic protocol was used, the
column was first degassed, dithionite (5 mM) was added to the equili-
brating buffer to remove dissolved dioxygen, and the manipulations
were performed in an anaerobic chamber. The column was then washed
with one column volume of the equilibrating buffer. DEAE-Sepharose
FF column fractionates the solubilized membranes into four fractions.
There are two flow-through fractions, a fast moving fraction (;10 ml)
containing a mixture of two forms of pMMO (see below) and a slow
moving fraction (;10–20 ml) containing positively charged proteins
(proteins of high pI), a truncated form of pMMO, and other impurities.
The bound proteins are eluted out using the above high ionic strength
buffer combining with a NaCl (or NH4Cl) gradient from 0 to 200 mM.
They are separated into two fractions. The fraction eluted out at ,100
mM NaCl (;200 ml) contained mostly the pMMO as judged from the
SDS-PAGE assay (purity .90%). The second fraction (50 ml or less)
eluted out of the column at higher salt concentration (.100 mM NaCl)
with a characteristic low pI and low molecular mass contaminant (;22
kDa) as well as other minor impurities. The isolated proteins were
concentrated using Amicon ultrafiltration membranes (Mr cut-off
50,000 or 100,000).
If desired, the binding fraction can be fractionated further using
QEA-Sephadex A-50, albeit with a significant reduction in recovered
activity. QEA-Sephadex A-50 column was equilibrated with buffer con-
taining 50 mM Pipes, 50 mM NaCl, 50 mM imidazole, 200 mM sucrose, 5
mM ascorbate, 200 mM CuSO4, and 0.03% (w/v) dodecyl b-D-maltoside,
pH ;7.2. The binding fraction was then applied to the column. The
pMMO can be eluted out using a NaCl (or NH4Cl) gradient. The pMMO
(a light green band) is normally eluted out at around 200 mM NaCl.
Lipids and Membrane-bound Quinone Isolation—Membrane suspen-
sions (protein concentration .20–30 mg/ml) were mixed with a meth-
anol/chloroform (1:3, v/v) mixture. The wet membrane suspension/ex-
traction solution mixture (typically 1:5 to 1:10, v/v) was shaken
rigorously and decanted. The process was repeated at least three times
to ensure complete extraction. The extracts were combined, dried over
anhydrous MgSO4, and decanted. After solvent removal, the crude
yellowish lipids were dried and stored under vacuum for later use.
Membrane-bound quinones were extracted using an ethanol/n-hex-
ane mixture (2:5, v/v). The extracts were combined, dried over MgSO4,
and decanted. After solvent removal, the isolated quinones were re-
duced by sodium borohydride. The resulting quinols, obtained as pre-
cipitates, were washed with a minimum amount of water and then with
ethanol, dried, and stored under vacuum for later use.
Protein Reconstitution—A 2–3-ml volume of the buffer containing
10–20 mg/ml of the isolated lipids was sonicated for 10–15 min to
disperse the lipids and mixed with 1 ml of purified protein in detergent-
containing buffer (protein concentration 20–30 mg/ml). The resulting
mixture can be sonicated briefly for a few seconds to assure dispersion.
As soon as the detergent-containing protein solution was added, the
solution became clear. The mixture was then loaded into dialysis tubing
(Mr cut-off 50,000 or 100,000). The tube was dialyzed against a buffer
containing 50 mM Pipes, 10 mM ascorbate, 200 mM CuSO4, 100 mM
(NH4)2SO4 for 12 h with continuous stirring. The reconstituted protein
was assayed immediately for activity and stored either at 4 °C or
280 °C for later use. The excess detergent can also be removed using
BioBeads SM-2. A volume of ;2–3 ml of the purified protein (;30–50
mg/ml) was passed through a column (1 3 5 cm) of Bio Beads, and the
eluate was concentrated using Amicon ultrafiltration membranes and
mixed immediately with a sonicated lipid suspension (10–20 mg/ml) as
described above (lipid/protein ratio 1:1 or 2:1, v/v). This mixture can be
sonicated briefly for a few seconds to ensure dispersion. The reconsti-
tuted protein was then assayed for activity immediately. The BioBeads
method did not prove to be a useful approach to prepare lipid-reconsti-
tuted protein, since the pMMO tended to precipitate out of the buffer as
soon as the detergent was removed.
MMO Activity Assay—The MMO activity of samples was measured
by alkane substrate (propane, butane) oxidation or propene epoxidation
assays. For membrane fractions, solubilized membranes, purified pro-
tein, and reconstituted pMMO, the reductant of choice was NADH.
Dithionite (3–5 mM) was also found to be capable of supporting turn-
over; however, it must be used in conjunction with a strong buffer (100
mM Pipes) and must be assayed using alkane substrates. Duroquinol
and membrane-originated quinols were tested as potential sources of
reducing equivalents. Duroquinone obtained from Sigma and quinones
isolated from the membranes were reduced by sodium borohydride and
purified as described above.
Each of the reductants was added to the membrane suspensions to
give a final concentration of 5 mM in a total volume of ;1.0 ml. The
assay was performed at 45 °C, and at ;5–7-min intervals, a 1-ml aliquot
of the solution was removed and injected directly onto a gas chromato-
graph for chemical analysis. Oxidation products were identified and
quantified by GC using a flame ionization detector. The activity of the
pMMO was determined from the limiting initial slope of product(s)
versus time plot. Specific activity was then obtained by dividing the
activity by the total amount of protein in the sample as determined by
the Lowry method.
SDS-PAGE, Protein Blotting, and N Terminus Sequencing—Each
pool of protein obtained during purification as well as the concentrated
purified protein was analyzed using SDS-PAGE (12.5–15%) according
to Laemmli (48). It is essential not to heat the protein in dissociating
buffer before loading, since this step results in substantial degradation
and cross-linking. The polypeptide bands were visualized by staining
with Coomassie Blue.
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The purified protein were first subjected to SDS-PAGE (12.5%) using
the protocols described above. The proteins were then blotted into
Immobilon-P membranes using the TransBlot apparatus (Bio-Rad)
with a modified procedure in which the SDS concentration in the
Tris/glycine transfer buffer was at least 0.2% (49, 50). Upon staining the
Immobilon-P membranes with Coomassie Blue to visualize the polypep-
tides, the bands corresponding to each subunit were excised, and the N
terminus sequence was determined using the Edman degradation
method.
Metal Assay—Metal ion analysis (copper, iron, zinc, cobalt, manga-
nese, and nickel) was performed by inductively coupled plasma-mass
spectroscopy. The copper concentration of the samples was determined
relative to standard solutions of Cu(NO3)2, ranging in concentration
from 7.3 to 155 mM in 0.1 N HNO3 (Aldrich). A solution of 0.1 N HNO3 in
distilled water was used as a copper-free control. Samples of purified
pMMO were used as obtained or digested at 45 °C using ultrapure
metal-free sulfuric acid obtained from Aldrich. The protein solution was
diluted with ultrapure water containing 0.1 N HNO3 to the appropriate
concentration prior to analysis. The values reported are the averages of
three separate determinations. The same samples were used for iron
analysis, but the standards were prepared by diluting an iron atomic
absorption standard purchased from Sigma with 0.1 N HNO3.
UV-visible and EPR Spectroscopy—EPR spectra were recorded on a
Varian E-line Century X-band spectrometer. In the EPR experiments,
sample temperature was maintained at 77 K with a liquid nitrogen
Dewar or at 4.2–100 K with an ESR-900 Oxford Instruments (Oxford,
United Kingdom) liquid helium cryostat. The EPR samples were pre-
pared by sealing 200 ml of protein solution under an atmosphere of
argon in quartz EPR tubes at a total protein concentration of ;50
mg/ml in 20 mM Pipes (pH 7.2). UV-visible spectra were taken using a
Hewlett-Packard HP 3502A UV-visible spectrometer.
RESULTS AND DISCUSSION
The Overproduction of Highly Enriched pMMO-containing
Membranes—The cultivation of methanotrophs is often
plagued by a foreign organism contamination, possibly another
methylotroph, which thrives on the byproducts of meth-
anotroph metabolism. As a result, samples of methanotroph
chemostat cultures were routinely withdrawn and scrutinized
under a microscope every 12 h to ensure the culture purity.
Only absolutely pure cultures as ascertained by microscopy
were subjected to membrane isolation and further experi-
ments. At low methane feeding rate conditions as described,
the release of methane metabolism by-products was mini-
mized, and bacterial contamination was completely eliminated.
In addition to eliminating bacterial contaminants, maintaining
a low methane feeding rate also stimulates the overproduction
of the intracytoplasmic membranes and the pMMO. We rou-
tinely obtain a minimum of 60% or more cellular mass in the
form of these membranes using growth conditions as described
above. In these membranes, the pMMO indeed constitutes the
bulk of the membrane-bound proteins (Fig. 1).
In the case of M. capsulatus (Bath), the addition of a sub-
stantial level of iron (.2 mM FeEDTA) often results in the
concomitant expression of sMMO in some bacterial population,
as evident by sMMO activity being detected in the soluble
fraction. Furthermore, sMMO associates itself rather tena-
ciously to the membrane fractions and distorts the activity or
oxidation product distribution when the membranes are as-
sayed using other hydrocarbon substrates. It can be also copu-
rified with the pMMO, hence giving a false impression of re-
covered activity. Therefore, care must be exercised to wash the
membranes thoroughly to remove cytosolic materials as much
as possible.
To obtain pMMO preparations with high and stable activity,
we have observed that it is essential to maintain relatively high
copper concentrations consistently throughout growth. High
levels of copper, however, must be coupled with low methane
feeding rates. High methane feeding rates give substantially
higher biomass, but the membrane yield is low. Furthermore,
low and unstable pMMO activity is frequently observed in
these membranes, which also contain significantly less copper.
Iron is also found to be another important element for growth,
but copper is the only ion found to be consistently crucial for
pMMO activity. These organisms have unusual tolerance for
high copper concentrations. The presumed toxicity of copper
ions was found to be due to the fact that that high CuSO4
concentrations (.50 mM) added to the nitrate mineral salts
medium buffered at pH ;7 cause a significant precipitation of
nutrients in the form of highly insoluble complexes. This pre-
cipitation depletes the pool of essential nutrients, resulting in
poor growth. The addition of CuEDTA to the growth medium,
along with CuSO4, to buffer the free Cu(II) concentration alle-
viates the depressed growth, as long as the pH is maintained
around 7 for the duration of the growth. This protocol allows us
to obtain high quality pMMO preparations routinely without
supplementing the medium with any other elements (iron
included).
Methodology for pMMO Isolation—To develop a suitable pro-
tocol for successful isolation of the active enzyme, several un-
usual features of the pMMO had to be recognized (1, 2). The
enzyme appears to require a lipid environment to function,
since solubilization often results in .90% loss of activity (44).
Previous attempts at isolating the protein indicated that once
being removed from the lipid bilayer, the enzyme deactivates
quickly. Our on-going characterization of the enzyme in situ
indicates that the enzyme contains an exceptionally high level
of Cu(I) ions, a unique feature for a monooxygenase (25, 26). As
such, the loss of activity upon solubilization and during puri-
fication could be a result of overoxidation and subsequent loss
of some of the more labile copper cofactors. In the protocols for
FIG. 1. SDS-PAGE of pMMO-overexpressed membranes iso-
lated from M. capsulatus (Bath). Lane 1, standards. Lanes 2 and 3,
electrophoretic profile of pMMO-overexpressed membranes isolated
from M. capsulatus (Bath) grown under methane stress conditions.
Note the absence of high molecular weight polypeptides in these
preparations.
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isolating the sMMO hydroxylase developed by Fox et al. (5), the
reduced form of iron was introduced into the isolating buffer,
resulting in preparations with a 10–20-fold increase in activity.
Similar approaches may not work for the pMMO, a copper-
containing protein, since an air-stable Cu(I) complex with a
high dissociation constant is not readily available. Despite the
fact that Cu(II) ions have been found to improve the pMMO
activity for certain pMMO preparations, the bulk of the copper
ions associated with the pMMO actually exists in the reduced
Cu(I) form. As Cu(I) ions are extremely insoluble in aqueous
solution, these copper sites are relatively inert. However, once
oxidized in an aerobic environment, they can become quite
labile, particularly for those copper cofactors that are relatively
exposed.
In light of these considerations, we have elected to develop
either an anaerobic procedure or an aerobic procedure that can
be carried out under an environment where copper oxidation is
minimized during solubilization and isolation. Accordingly, in
our protein isolation and purification experiments, copper oxi-
dation was minimized by using deoxygenated buffer, perform-
ing manipulations in an anaerobic chamber, and by adding
dithionite (2–5 mM) to the buffers to remove dissolved oxygen.
Indeed, our first successful attempt at recovering activity from
purified pMMO was achieved using a protocol in which de-
gassed buffer was used with an excess of ascorbate to reduce all
the copper ions in the preparation.
Another unusual feature of the pMMO system is that the
enzyme is overexpressed in the membranes. As such, the main
purpose of the isolation procedure is not to enrich the pMMO
several hundred- or thousand-fold, as is commonly done for
many other proteins and enzymes, but the objective is to re-
move other contaminating proteins in the membranes, partic-
ularly heme proteins and other iron-containing proteins, as
much as possible. Once purified, we relied on reconstitution
experiments on these pMMO preparations to optimize the re-
covered activity.
Components of the pMMO System—Assuming that we can
isolate intact pMMO with full metal content, it does not follow
that we will observe optimal activity, since maximal activity
may require the presence of other crucial components such as a
pMMO reductase and possibly an activity-regulatory protein.
The existence of a pMMO reductase is certain, since NADH, a
reductant capable of supporting pMMO turnover in vitro is a
two-electron donor, while each copper ion is a one-electron
acceptor. This fact suggests the presence of a mediator. From
the available literature, we can postulate possible types of
reductase systems for the pMMO. A two-component pMMO
system would consist of a pMMO hydroxylase and a reductase
that accepts electrons from NADH and channels them directly
to the hydroxylase, a scenario found to be the case for the
sMMO. A three-component system might consist of a pMMO
hydroxylase; a mediator component, which could be a species
like cytochrome b or c or a quinone analog; and a NADH
oxidoreductase, which accepts electrons from NADH and chan-
nels them to the mediator molecule. Depending on the nature of
the mediator, this oxidoreductase could be a NADH/quinone
oxidoreductase or a NADH/cytochrome oxidoreductase and
could be either membrane-bound or membrane-soluble. Recent
results of Shiemke et al. (51) suggest that the pMMO system
might be a three-component quinone oxidoreductase/quinol/
hydroxylase. Confirmation of this hypothesis can be readily
made by assaying the enzyme in the form of membrane-bound,
solubilized, or purified/reconstituted pMMO hydroxylase using
the quinones isolated from the membranes, purified and re-
duced as described. However, a conclusive result has yet to be
obtained. In any case, this scenario now seems rather unlikely,
with the recent isolation and characterization of a flavin-con-
taining NADH oxidoreductase that appears to be associated
with the pMMO.2
Characterization of the Purified pMMO Hydroxylase Activity:
Metal Content—The major protein isolated from the mem-
branes from now on will be referred to as the pMMO hydroxy-
lase (pMMOH). The isolated pMMOH upon detergent removal
and lipid reconstitution exhibits a significant level of recovered
activity (Table I). Although the recovered activity has yet to be
as high as the level in whole cells or in our most active mem-
brane preparations to date, the level of observed activity is
significant enough for us to draw important and critical con-
clusions regarding the nature of the pMMO.
Although the membrane fractions contain certain levels of
iron (the copper/iron ratio fluctuates greatly, ranging from 7:1
to 20:1 or higher), the purified pMMOH contains only copper
ions (Table I). Since only copper ions are detected in these
active preparations, one can conclude now that copper, not iron,
is the metallic cofactor of the pMMOH and constitutes the
active site(s) of the enzyme. Even in inactive and “purified”
pMMOH preparations, copper was also the only metal ion
detected in any significant and stoichiometric amounts. A re-
cent report regarding the ammonia monooxygenase (AMO) iso-
lated from Paracoccus denitrificans also indicates that only
copper was found in the purified enzyme (52). Considering the
sequence homology shared by the two enzymes and biochemical
similarities between the pMMOH and the AMO (2, 40, 52–59),
metal analysis of the AMO is consistent with our conclusion
that the pMMOH contains copper only; in other words, it is a
copper protein. The number of copper ions in active prepara-
tions is high (12–15 copper atoms/protein molecule). It has been
suggested that the copper ions in pMMOH can be grouped into
two distinct classes of copper on the basis of their preferential
functions. These copper ions have been referred to by their
roles in either catalysis (C-copper) or electron transfer (E-
copper). In active and purified preparations of the pMMOH, a
significant amount of copper is reduced (26). These Cu(I) ions
(the E-copper ions) could serve as the source of endogenous
reducing equivalents for turnover and hence probably were
partially responsible for the observed recovered activity upon
lipid reconstitution in the absence of added external reductant
like NADH. The presence of Cu(I) ions in the pMMOH is
consistent with other studies known to date regarding the
biochemistry of the pMMO and AMO (2). Both pMMO and
2 S. J. Elliott and S. I. Chan, unpublished data.
TABLE I
Metal content and activity of representative
purified pMMO hydroxylase preparations
Copper/Proteina Iron/Protein Activityb
mmol/mg protein mmol/mg protein nmol/min z mg protein
0.141c (15) ;0.00d 2.6e (9.66, 27%)
0.133f (12.4) ;0.00 5.1e (12.5, 41%)
a The number of copper atoms per protein molecule is shown in
parentheses. It was determined assuming that the monomeric pMMO
hydroxylase has a subunit composition of abg and a molecular mass of
94 kDa.
b The membrane activity and percentage of recovered activity are
shown in parentheses.
c This preparation was prepared using the DEAE-Sepharose
procedure.
d The residual level of iron in the purified pMMO is a copper/iron
ratio of ;70–100:1.
e NADH was used as electron donor in the activity assay. Dithionite
as reductant also yielded comparable results. The recovered activity
was found to vary from preparation to preparation.
f This preparation was obtained using the L-lysine-agarose protocol.
Particulate Methane Monooxygenase from M. capsulatus 7961
AMO are known to be very sensitive to copper chelators, par-
ticularly the ones highly specific to Cu(I) ions (for instance,
allylthiourea) and are sensitive to light, a possible manifesta-
tion of Cu(I) photochemistry (2). Thus, it is understandable
that the isolation of active AMO was achieved by using a
protocol performed in the dark, which is consistent with the
inactivation of Cu(I) ions in the enzyme by light (52). Growth
inhibition by light was observed for certain methanotrophs that
are known to express only the pMMO (1, 2).
Since the number of copper ions per monomeric unit (94 kDa)
is high, it is evident that the copper ions cannot all be ligated by
multiple histidines, since there are only 11 histidine residues
in the gene sequences of pmoA and pmoB published to date,
and not all of these histidines are conserved and positioned at
suitable locations for copper ligation (e.g. the conserved histi-
dine residue at the N terminus). It also seems likely that many
of these copper ions may be ligated to the nitrogen atoms in the
peptide backbone or other side chain ligands, such as the car-
boxylates of glutamates and aspartates. These “hard” peptide-
backbone nitrogen and carboxylate ligands of the pMMO-asso-
ciated copper ions may explain several unique aspects of the
copper chemistry exhibited by the enzyme. Since this type of
coordination sphere confers rather weak binding to Cu(I) ions
and since these E-copper ions are located in the exposed do-
mains of the proteins,2 they are readily disrupted during pro-
tein isolation and purification and oxidized to Cu(II). Once
oxidized and dissociated, the enhanced solubility of the Cu(II)
ions renders the inactivation process irreversible. This scenario
explains in part the lability of the E-coppers as well as the
rapid loss of the enzyme activity when they become oxidized.
The fact that our pMMO preparations contain only copper
ions is in conflict with a recent report, which suggested that the
pMMO may contain iron (45). The presence of iron in the latter
pMMO preparation is clearly a result of unaccounted for iron-
containing contaminants in the preparations as well as the
experimental protocols employed in the study, where the or-
ganisms were cultivated under unusually high iron concentra-
tions. Cultivating the organism in the presence of excess iron
(60 mM) could have significant physiological consequences,
ranging from concomitant sMMO expression and the expres-
sion of iron transport and storage proteins (bacterial ferritin) to
increases in nonspecific iron binding, etc.
DiSpirito et al. (53) also reported the isolation of an aa3-type
oxidase and an aa3-cytochrome c complex from the membranes
isolated from M. capsulatus (Bath). This oxidase preparation
contained at least 7–10 copper and 2–3 iron atoms/94-kDa
monomer. An electrophoretic profile of this oxidase prepara-
tion, however, showed remarkable similarity to the pMMO
polypeptides reported here. Considering the level of copper ions
in oxidases isolated from other organisms (2–3 copper atoms/
monomer), it is clear that this oxidase preparation was heavily
contaminated by the pMMO. On the other hand, we have
observed only ba3-type oxidase so far in the membranes iso-
lated from M. capsulatus (Bath). In light of the likelihood of
bacterial contamination noted earlier, efforts to isolate oxidase
from these membranes must ensure that the methanotroph
culture used is pure. It should also be noted that attempts to
isolate oxidase from these membranes are hampered by the low
expression levels of the oxidase compared with those of the
pMMO. Our results indicated that the oxidase level in the
membranes is very low, at most constituting ;2–3% of total
membrane proteins. The existence of an oxidase, however,
points to the presence of electron transport chain complexes
(complexes I, II, and III) in the membranes. These respiratory
enzymes contain mostly heme-iron and iron-sulfur clusters.
The existence of these multiple iron-containing proteins ex-
plains the presence of iron in the membranes detected previ-
ously (24, 27–29). On the basis of the observed level of oxidase
expression, ;10–15% of total membrane proteins are probably
respiratory enzymes. This expression level of these enzymes,
which contain an average of 5–7 iron atoms/monomer of respi-
ratory enzyme, affords an estimate of a membrane copper/iron
ratio of 7–20:1, given that the pMMO expression level is ;60–
80% of total membrane proteins and that the average level of
copper incorporation into the pMMO is ;15 copper atoms/94
kDa. This is indeed the ratio observed (24–29). These results
reinforce the conclusion that the pMMOH is a copper protein
only.
Subunit Composition of the pMMO Hydroxylase and pMMO
Polymorphism—Purification of pMMOH from solubilized mem-
branes and assaying of the polypeptide profile of the collected
fractions demonstrates that three polypeptides are consistently
co-purified together concomitant with recovered activity. This
result suggests that at least one form of pMMO contains three
subunits, since co-elution during purification is one of the cri-
teria to determine the subunit association of an enzyme. SDS-
PAGE analysis of the purified pMMOH fractions obtained from
these experiments indicates an apparent molecular mass of 45,
26, and 23 kDa, for these subunits, named a, b, and g, respec-
tively (Fig. 2, lane 3). The assertion that the pMMOH contains
a core of three different subunits is also supported by the
observation that in several highly active and stable prepara-
tions, electrophoretic profiles of membranes (as well as purified
pMMO) display only three major bands intensely, implying
that these three subunits are all of the essential membrane-
bound components needed for pMMO activity. The 35-kDa
FIG. 2. SDS-PAGE of fractions obtained from DEAE-Sepharose
chromatography of solubilized membranes isolated from M.
capsulatus (Bath). Lane 1, standards. Lane 2, fraction 1 (flow-
through, fast moving fraction). Note the prominent presence of all of the
45-, 35-, 26-, and 23-kDa polypeptides. The purity of the pMMO (both
forms of the enzyme) in this fraction is estimated at .70%. Lane 3,
fraction 2 (flow-through, slow moving fraction). Note the near absence
of the 45-kDa band; however, the 35-kDa band is still present (albeit
with smearing) as well as the ;26- and ;23-kDa bands. The presence
of lightly stained high and low molecular weight polypeptides can also
be seen. Lane 4, fraction 3 (weakly binding fraction eluted at ,100 mM
NaCl or NH4Cl). This fraction is mostly the pMMO (purity .90%). The
26-kDa band exhibits some smearing. Lane 5, fraction 4 (strongly bind-
ing fraction eluted at .100 mM NaCl or NH4Cl). This fraction contains
mostly a very low pI, 24-kDa polypeptide which has an N-terminal
sequence of AAQASLERNL. Other minor impurities can also be seen.
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polypeptide observed previously in MMO expression switch-
over experiments is absent in these preparations (35–39) (see
below).
The 45-kDa subunit is one of the polypeptides observed pre-
viously in the electrophoretic profile of the membranes when
the organism switches from sMMO to pMMO expression (35–
39). In these experiments, when the organism switches from
sMMO to pMMO expression, increasingly higher levels of the
45- and 26-kDa polypeptides were observed concomitantly with
decreasing amounts of sMMO hydroxylase-associated polypep-
tides (35–39). We surmise that the E-clusters reside in the
exposed domains of this subunit on the cytoplasmic side. The
26-kDa subunit is the acetylene-binding polypeptide, which
almost certainly contain the C-clusters, namely, the active
site(s) of the enzyme (24–29). This subunit contains an N-
terminal sequence identical to the gene sequence already re-
ported, except it started with a serine residue instead of a
methionine (40, 54). The function of the 23-kDa subunit is not
clear at the moment. Since previous studies did not detect its
presence, it remains to be established that this subunit is
conserved in all methanotrophs.
The N-terminal sequences of these pMMO subunits have
been determined using Edman degradation, and the results are
tabulated in Table II. Using oligonucleotide probes derived
from these N terminus sequences, Lidstrom and co-workers
(25, 40, 54) have identified two copies of the genes coding these
polypeptides and have determined their gene sequences. The
genes encoding these subunits have been named pmoA (26
kDa), pmoB (45 kDa), and pmoC (23 kDa). The closely arranged
proximity of these pMMO genes is further evidence in strong
support of a three-subunit pMMO hydroxylase.
The presence of two pMMO gene copies first suggested that
two distinct forms of the enzyme may exist. Sequencing results,
however, have indicated that the two pMMOH structural genes
are almost identical, hence the existence of significantly differ-
ent forms of the pMMO in terms of primary sequence is un-
likely (25). Instead, the presence of almost identical multiple
pMMO gene copies suggests a genetic mechanism for control of
the level of enzyme expression; i.e. the level of pMMO expres-
sion can be altered by the rate of protein synthesis via a
transcription mechanism in response to metabolic need. This
conclusion implies that pMMO can be overexpressed, and it is
found to be the case. As described above, the conditions for
pMMO overexpression have been identified and exploited, al-
lowing us to obtain large quantities of the membranes contain-
ing mostly pMMO.
As first suggested by the N-terminal sequence of these
polypeptides and later by the amino acid sequence deduced
from the genes cloned to date, it is clear that pMMOH and
AMO do not exhibit significant homology to any proteins se-
quenced to date (40, 54–59). This result establishes that
pMMO is indeed a novel enzyme that together with AMO
constitutes a new class of copper-containing proteins. These
two enzymes share about ;40% homology on the gene portion
already sequenced, significantly enough to indicate that these
two enzymes are evolutionary related (54).
The above described results establish that the 45- and 26-
kDa polypeptides and the newly elucidated 23-kDa polypeptide
are parts of the pMMO hydroxylase complex. However, when
the organism switches from sMMO to pMMO expression, a
35-kDa polypeptide has been observed as well, and its role has
yet to be resolved. In several membrane preparations exhibit-
ing high and stable activity, this polypeptide is also observed in
significant levels, regardless of switch-over conditions, and it
copurified with the three polypeptides described above (Fig. 2,
lanes 1 and 2). This result suggests the formation of a tight
complex among these polypeptides that does not dissociate
under purification conditions. To our surprise, this 35-kDa
polypeptide contains an N-terminal sequence identical to that
of the large 45-kDa subunit. This result indicates that it is a
product of the C terminus proteolytic cleavage of the 45-kDa
subunit. However, since it is copurified or observed with two or
three other subunits, it is likely that it is part of another form
of the pMMO instead of a proteolytic degradation of the 45-kDa
subunit. Two possible scenarios can account for this result. The
first scenario is that there are three-subunit (abg) and four-
subunit forms of the pMMO (a1a2bg), where a1 and a2 are the
45- and 35-kDa polypeptides, respectively. The other possibility
is that there are two forms of the three-subunit pMMO. One
form is composed of the 45-, 26-, and 23-kDa polypeptides
(abg), while the other consists of the 35-, 26-, and 23-kDa
polypeptides (a9bg). The latter scenario is more consistent with
our data, since we have obtained fractions containing mostly
the 35-, 26-, and 23-kDa polypeptides with only a minor pres-
ence of the 45-kDa polypeptide (Fig. 3, lane 1). In this prepa-
ration, we obtained two distinct fractions with significantly
different polypeptide compositions (Fig. 3, lanes 1 and 2), and
the intensity of the bands in this preparation is consistent with
a protein with a subunit composition of 35-, 26-, and 23-kDa
polypeptides (Fig. 3, lane 1). As such, the 35-kDa polypeptide
may be a post-translational modified version of the 45-kDa
subunit. The process of proteolytic maturation via extensive
peptidase action could lead to new folding structure and differ-
ent catalytic properties. The presence of this 35-kDa polypep-
tide, however, has been observed only for the M. capsulatus
(Bath) strain. Taken together, the nearly identical but multiple
gene copies for each subunit, the variation in the N-terminal
sequence, and the existence of a proteolytic processed version of
the enzyme all point to a unique and rather unexpected se-
quence, composition, and structural polymorphism regarding
the pMMO hydroxylase.
Spectroscopic Characterization of the Purified pMMO Hy-
droxylase—The UV-visible and EPR spectra of various purified
pMMO preparations are shown in Figs. 4, 5, 6, and 7. The
purified pMMOH also appears not to contain any other com-
mon biological cofactors as suggested by its UV-visible absorp-
tion spectrum (Fig. 4). The UV-visible spectrum of the purified
pMMOH exhibits only the protein absorption (;280–300 nm)
and a very weak band at 410 nm that can be attributed to a
very slight cytochrome contaminant(s). Further efforts to re-
move the cytochrome contaminants resulted in complete deac-
tivation of the enzyme and hence were not pursued further.
The purified pMMOH also exhibited an EPR spectrum sim-
ilar to the spectrum of the overexpressed pMMO membranes
reported previously (Fig. 5). This EPR spectrum is typical of
Cu(II) ions in a quasi-square planar coordination environment.
As noted earlier, most of the E-cluster coppers remain reduced
TABLE II







a Approximately 90% of the 35-kDa band had the above sequence.
This sequence was obtained using the pMMO fraction shown in Fig. 3,
lane 1. The minor 10% contaminant of this 35-kDa polypeptide ap-
peared to have the following N-terminal sequence: ARPLIDLALTL-
DIPD.
b Polypeptides with the following N-terminal sequences were also
observed: AAEAPLKDKKWLTFA and AEAPLKDKKWLTFA.
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following the isolation and purification, and the EPR spectrum
observed arises from the turnover of the C-cluster coppers by
dioxygen.
The coppers of the purified pMMO can also be fully oxidized
by ferricyanide treatment. Excess oxidant was removed by
repeated washing. This preparation exhibited a quasi-isotropic
EPR signature (Fig. 6), which has been attributed to trinuclear
copper clusters (25, 26). The observed EPR intensity is consist-
ent with the oxidation of all 15 copper ions arranged in the five
trinuclear clusters. Interestingly, the ferricyanide-oxidized
pMMO showed a broad optical absorption band at ;500 nm
(Fig. 7). The origin of this absorption band will be examined in
future investigations.
Factors Contributing to pMMO Activity Stability and Kinet-
ically Distinct pMMO Forms—Maintaining high copper con-
centrations during growth has a marked effect on the isolated
membranes, particularly higher and longer lasting activity in
vitro. Equally important factors are cell growth/life cycle, pH,
and levels of copper oxidation in solution (which are linked to
dioxygen tension). Cell cycle is critical, since we obtain prepa-
rations with stable activity only with mature cells grown on
Petri plates for more than 7 days and less than 4 weeks. The pH
strongly affects the activity of the enzyme. Upon exposure of
highly active membrane preparations to acidic pH (pH ,7, or
even a short exposure to 6.8), the membranes quickly lose all of
the activity. While readjusting the pH to physiological ranges
(7.2), no activity, or at best base-line activity, can be observed.
Interestingly, certain membrane preparations become acidic
rather quickly upon direct exposure to atmospheric oxygen,
and once this phenomenon occurs, all activity is lost quickly. It
has become clear to us that this is the underlying reason for the
unusual instability of the pMMO activity: in all instances
where activity is lost at any stage (cell lysis, membrane isola-
tion, membrane solubilization, or the thawing of frozen mem-
branes), a significant drop in pH is always observed.
This proton release phenomenon is linked to dioxygen ten-
sion (hence to copper oxidation). In several preparations, when
treating these membranes with pure dioxygen (even prolonged
storage at 4 °C, thus allowing more reaction time), a drop in pH
is observed, and all pMMO activity is lost. Adding reductants
(ascorbate or NADH) or deoxygenating the membranes does
extend the life of these preparations, suggesting a link between
dioxygen tension and copper oxidation with the observed pro-
ton release and activity loss. At the moment, it appears that the
reaction of dioxygen with pMMO in the absence of substrates
triggers the release of internal protons in this form of the
pMMO. The source of these protons is yet to be determined,
although they may be associated with glutamate/aspartate side
chains that are not ligated to copper ion(s), as would be the case
when the protein is not loaded with its full complement of
copper cofactors. On the basis of the buffer strength (20 mM
Pipes, pKa ;6.8), the magnitude of the pH drop (from 7.2 to
6.6), and the protein concentration (;50 mg/ml), the level of
proton release is estimated to be ;10 H1/94-kDa protein
monomer.
On the basis of results obtained to date, three kinetically
distinct pMMO forms can be distinguished. Type I pMMO is
the stable form. This form exhibits moderate but stable specific
activity in vitro and is also stable with respect to repeated
freeze-thaw cycles and prolonged storage at 280 °C. Type I
pMMO is isolated only from slow growing bacteria and has
been described in great detail in this paper. As a result of its
enhanced stability, it is the most suitable for isolation. In-
creases in dioxygen tension (treating the protein suspensions
with pure dioxygen or aerobic storage at 4 °C) will result in the
formation of the “pulsed” state of the enzyme, which exhibits
severalfold increases in activity in vitro, and only a minimal
amount of proton release is observed (1–2 H1/94-kDa mono-
mer). Type II pMMO is the highly unstable form that is pre-
FIG. 3. SDS-PAGE of two major fractions obtained from DEAE-
Sepharose chromatography of unusual solubilized membranes
isolated from M. capsulatus (Bath). Lane 1, low ionic strength
fraction (,100 mM), where the 35-kDa polypeptide is prominent. The
35-, 26-, and 23-kDa band intensities are nearly the same, whereas the
45-kDa band is virtually absent. Lane 2, high ionic strength fraction
(.100 mM), where the 45-, 26-, and 23-kDa band intensities are nearly
the same, whereas the 35-kDa band is almost completely absent.
FIG. 4. UV-visible spectrum of the purified pMMO that has the
abg (45-, 26-, and 23-kDa) subunit composition. Note the presence
of a very weak absorption band at ;410 nm due to minor heme con-
tamination. The concentration was 2.3 mM (inset, 40.6 mM) at pH 7.2 in
25 mM Pipes buffer and 0.05% dodecyl b-D-maltoside.
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dominantly expressed by fast growing bacteria even under
methane stress conditions (cell density often exceeds 8–10
g/liter of culture). Upon cell lysis and direct exposure to atmo-
spheric oxygen pressure, it releases many protons (.10 H1
released/94 kDa) and quickly loses all activity within 6 h after
cell breakage. Activity assays using cell-free extracts in the
first hour after cell lysis, however, indicate that this form
exhibits extremely high specific activity, initially several times
higher than type I pMMO. Anaerobic storage, and the addition
of reductants like ascorbate to the buffer do prolong its activity.
Type III pMMO is an intermediate between the two aforemen-
tioned forms and is most often obtained. This form is quite
stable at first to direct exposure to atmospheric dioxygen ten-
sion, but the activity decays over several days and is unstable
with respect to freezing and solubilization. Increased dioxygen
tension does not lead to the formation of the pulsed state;
instead, a significant drop in pH occurs (;5–7 H1 released/94
kDa), and all activity is lost. Thawing frozen membranes of this
type also leads to a substantial proton release and loss of
activity.
The fact that the pMMO is sensitive to dioxygen and prone to
inactivation as a result of dioxygen overexposure is surprising.
However, ample evidence to indicate this dioxygen sensitivity
can be found in the methanotroph literature. First and fore-
most, this characteristic reflects the environment of meth-
anotrophs’ natural habitat, namely the interface between an-
aerobic and aerobic environments, where there is sufficient
methane but low dioxygen pressure. The shock of increased
dioxygen pressure is enough to deactivate the enzyme (types II
and III), which is consistent with the observation that meth-
anotrophic growth is often slowed down or inhibited under
normal atmospheric oxygen pressure (1, 2). The existence of the
exception (type I pMMO), however, is a manifestation of an
amazing biodiversity that allows the organisms not only to cope
with but also to thrive under the many challenges of their
environments.
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FIG. 5. The X-band EPR spectrum of
the purified pMMO as isolated. The
spectrum was recorded at the tempera-
ture of 8 K with microwave power of 0.1
milliwatt, modulation frequency of 100
kHz, modulation amplitude of 10 Gauss,
and gain of 8 3 103. See “Materials and
Methods” for protein concentration.
FIG. 6. The X-band EPR spectrum of the fully oxidized purified
pMMO obtained by ferricyanide treatment. Excess ferricyanide
was removed by repeated washing. The spectrum was recorded at 4 K
with microwave power of 0.05 milliwatt, modulation frequency of 100
kHz, modulation amplitude of 10 Gauss, and gain of 4 3 103. See
“Materials and Methods” for protein concentration.
FIG. 7. UV-visible spectrum of the fully oxidized purified
pMMO that has the abg (45-, 26-, and 23-kDa) subunit composi-
tion. Note the appearance of a broad absorption band at ;500 nm in
addition to the ;400-nm band observed previously in the purified
as-isolated pMMO. The concentration was 3.7 mM (inset, 37 mM) at pH
7.2 in 25 mM Pipes buffer and 0.05% dodecyl b-D-maltoside.
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